Nicosia S - Search Results

1

Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.

Capra V, Bolla M, Belloni PA, Mezzetti M, Folco GC, Nicosia S, Rovati GE. Capra V, et al. Among authors: nicosia s. Br J Pharmacol. 1998 Feb;123(3):590-8. doi: 10.1038/sj.bjp.0701636. Br J Pharmacol. 1998. PMID: 9504401 Free PMC article.

2

Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.

Ravasi S, Capra V, Panigalli T, Rovati GE, Nicosia S. Ravasi S, et al. Among authors: nicosia s. Biochem Pharmacol. 2002 Apr 15;63(8):1537-46. doi: 10.1016/s0006-2952(02)00889-4. Biochem Pharmacol. 2002. PMID: 11996896

3

Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: novel mechanisms of action independent of the anti-histamine activity.

Letari O, Miozzo A, Folco G, Belloni PA, Sala A, Rovati GE, Nicosia S. Letari O, et al. Among authors: nicosia s. Eur J Pharmacol. 1994 Feb 15;266(3):219-27. doi: 10.1016/0922-4106(94)90130-9. Eur J Pharmacol. 1994. PMID: 8174605

4

Working hypothesis on the classification of Cys-leukotriene receptors in airways.

Capra V, Rovati GE, Nicosia S. Capra V, et al. Among authors: nicosia s. Ann N Y Acad Sci. 1997 May 30;812:169-70. doi: 10.1111/j.1749-6632.1997.tb48161.x. Ann N Y Acad Sci. 1997. PMID: 9186731 No abstract available.

5

Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma.

Capra V, Nicosia S, Ragnini D, Mezzetti M, Keppler D, Rovati GE. Capra V, et al. Among authors: nicosia s. Mol Pharmacol. 1998 Apr;53(4):750-8. doi: 10.1124/mol.53.4.750. Mol Pharmacol. 1998. PMID: 9547367

6

Receptors for cysteinyl-leukotrienes in human cells.

Nicosia S, Capra V, Accomazzo MR, Ragnuni D, Ravasi S, Caiani A, Jommi L, Saponara R, Mezzetti M, Rovati GE. Nicosia S, et al. Adv Exp Med Biol. 1999;447:165-70. doi: 10.1007/978-1-4615-4861-4_15. Adv Exp Med Biol. 1999. PMID: 10086192 Review. No abstract available.

7

Evaluation of the pharmacological activity of the pure cysteinyl-leukotriene receptor antagonists CGP 45715A (iralukast) and CGP 57698 in human airways.

Capra V, Ravasi S, Bolla M, Viappiani S, Pagliardini S, Belloni PA, Mezzetti M, Folco GC, Nicosia S, Rovati GE. Capra V, et al. Among authors: nicosia s. Adv Exp Med Biol. 1999;469:313-8. doi: 10.1007/978-1-4615-4793-8_46. Adv Exp Med Biol. 1999. PMID: 10667347 No abstract available.

8

Binding to cysteinyl-leukotriene receptors.

Nicosia S, Capra V, Ravasi S, Rovati GE. Nicosia S, et al. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S46-50. doi: 10.1164/ajrccm.161.supplement_1.ltta-10. Am J Respir Crit Care Med. 2000. PMID: 10673226 Review. No abstract available.

9

A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.

Ravasi S, Capra V, Mezzetti M, Nicosia S, Rovati GE. Ravasi S, et al. Among authors: nicosia s. Mol Pharmacol. 2000 Jun;57(6):1182-9. Mol Pharmacol. 2000. PMID: 10825389 Free article.

10

Leukotrienes as mediators of asthma.

Nicosia S, Capra V, Rovati GE. Nicosia S, et al. Pulm Pharmacol Ther. 2001;14(1):3-19. doi: 10.1006/pupt.2000.0262. Pulm Pharmacol Ther. 2001. PMID: 11162414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters